Pancreatic Adenocarcinoma, Version 1.2019.

Margaret A Tempero, Mokenge P Malafa, E Gabriela Chiorean, Brian Czito, Courtney Scaife, Amol K Narang, Christos Fountzilas, Brian M Wolpin, Mahmoud Al-Hawary, Horacio Asbun, Stephen W Behrman, Al B Benson, Ellen Binder, Dana B Cardin, Charles Cha, Vincent Chung, Mary Dillhoff, Efrat Dotan, Cristina R Ferrone, George Fisher, Jeffrey Hardacre, William G Hawkins, Andrew H Ko, Noelle LoConte, Andrew M Lowy, Cassadie Moravek, Eric K Nakakura, Eileen M O'Reilly, Jorge Obando, Sushanth Reddy, Sarah Thayer, Robert A Wolff, Jennifer L Burns, Griselda Zuccarino-Catania

Journal of the National Comprehensive Cancer Network : JNCCN 2019 March 2

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

Full text links

We have located links that may give you full text access.

Show additional links to paperHide additional links to paper

PubMed

Add to Saved Papers

Get 1-tap access

Related Resources

For the best experience, use the Read mobile app

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app